XY LLC is the master licensee in control of all sperm sorting in non-human mammals worldwide. The XY sex selection technology creates the ability to choose the sex of the offspring using sexed semen or sexed embryos.
We are committed to excellence in the advancement of reproductive science and in service to XY LLC licensees worldwide.
XY LLC (formerly XY Inc.), an innovative leader in the livestock reproduction industry and primary promoter for commercialization of sperm sexing technology in animals, was just awarded an US$8.5 million dollar judgment against one of its former licensees, JingJing Genetics Inc. of Canada and JingJing's principals Jesse Jia-Bei Zhu, Selen Cui Feng Zhou and Jin Tang.
Australia's regenerative medicine company, Mesoblast Limited (ASX:MSB)(PINK:MBLTY), today announced highly successful preclinical trial results of its adult stem cells in the treatment of degenerative intervertebral disc disease, the leading cause of low back pain.